Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a No longer looking for participants notice indicating enrollment has ended. The label for the Intervention/Treatment section was updated (from Intervention / Treatment), and the revision version changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page revision label updated from v3.5.4 to v3.5.5, indicating a small internal update that does not alter the study content or user-facing information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision label. This reflects a new release/version of the study record display.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision label, Revision: v3.5.3, was added, and the previous Revision: v3.5.2 label was removed, updating the page's version history.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed; this appears to be a platform version update with no visible changes to the study details.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision metadata updated: v3.5.0 added; v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.